March 20 (Reuters) - Kalytera Therapeutics Inc KALY.V :
* KALYTERA INITIATES PROGRAM TO DEVELOP A NOVEL CANNABINOID-BASED COMPOUND FOR TREATMENT OF ACUTE AND CHRONIC PAIN
* KALYTERA THERAPEUTICS INC - KALYTERA OBTAINED AN EXCLUSIVE, WORLDWIDE LICENSE FOR COMPOUND FROM BEETLEBUNG PHARMA, LTD